Prof. Chris Goldring
Chair of Molecular and Cellular Pharmacology at University of Liverpool
Professor Chris Goldring has more than twenty years of experience of molecular bioanalysis, working with cell culture, in vitro and in vivo models, particularly looking at how the liver responds to pharmaceutical compounds. He leads the molecular and cellular toxicology group within the Centre for Drug Safety Science (CDSS), a UK centre based at the University of Liverpool, with a critical mass of scientists studying mechanisms of adverse reactions to therapeutics. He is also academic coordinator of the Industry-Academic Innovative Medicines Initiative project TransQST (2017-2022).